Capital Analysts, LLC Pfizer Inc Transaction History

Capital Analysts, LLC

  • $2.26 Billion
  • Q2 2024

A detailed history of Capital Analysts, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capital Analysts, LLC holds 21,961 shares of PFE stock, worth $651,363. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,961
Previous 20,193 8.76%
Holding current value
$651,363
Previous $560,000 9.82%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$25.26 - $29.6 $44,659 - $52,332
1,768 Added 8.76%
21,961 $615,000
Q1 2024

May 14, 2024
SELL
$25.89 - $29.73 $33,760 - $38,767
-1,304 Reduced 6.07%
20,193 $560,000
Q4 2023

Jan 30, 2024
SELL
$26.13 - $33.94 $1.17 Million - $1.52 Million
-44,884 Reduced 67.62%
21,497 $619,000
Q3 2023

Nov 13, 2023
SELL
$32.09 - $37.51 $24,998 - $29,220
-779 Reduced 1.16%
66,381 $2.2 Million
Q2 2023

Aug 11, 2023
BUY
$36.12 - $41.79 $101,461 - $117,388
2,809 Added 4.37%
67,160 $2.46 Million
Q1 2023

May 05, 2023
BUY
$39.39 - $51.28 $152,084 - $197,992
3,861 Added 6.38%
64,351 $2.63 Million
Q4 2022

Feb 08, 2023
BUY
$41.75 - $54.5 $58,784 - $76,736
1,408 Added 2.38%
60,490 $3.1 Million
Q3 2022

Nov 14, 2022
BUY
$43.76 - $53.42 $46,516 - $56,785
1,063 Added 1.83%
59,082 $2.59 Million
Q2 2022

Aug 12, 2022
BUY
$46.53 - $55.17 $53,649 - $63,611
1,153 Added 2.03%
58,019 $3.04 Million
Q1 2022

May 12, 2022
SELL
$45.75 - $56.69 $455,715 - $564,689
-9,961 Reduced 14.91%
56,866 $2.94 Million
Q4 2021

Feb 10, 2022
SELL
$41.32 - $61.25 $35,328 - $52,368
-855 Reduced 1.26%
66,827 $3.95 Million
Q3 2021

Nov 04, 2021
BUY
$39.25 - $50.42 $82,739 - $106,285
2,108 Added 3.21%
67,682 $2.91 Million
Q2 2021

Nov 15, 2021
SELL
$35.91 - $40.68 $286,777 - $324,870
-7,986 Reduced 10.86%
65,574 $2.57 Million
Q2 2021

Aug 05, 2021
BUY
$35.91 - $40.68 $243,541 - $275,891
6,782 Added 10.16%
73,560 $2.88 Million
Q1 2021

May 17, 2021
BUY
$33.49 - $37.77 $672,412 - $758,346
20,078 Added 42.99%
66,778 $2.42 Million
Q4 2020

Feb 16, 2021
SELL
$33.47 - $42.56 $104,560 - $132,957
-3,124 Reduced 6.27%
46,700 $1.72 Million
Q3 2020

Nov 12, 2020
SELL
$31.75 - $37.25 $17,303 - $20,301
-545 Reduced 1.08%
49,824 $1.83 Million
Q2 2020

Aug 07, 2020
SELL
$30.12 - $36.54 $31,595 - $38,330
-1,049 Reduced 2.04%
50,369 $1.65 Million
Q1 2020

May 08, 2020
BUY
$27.03 - $38.62 $145,989 - $208,586
5,401 Added 11.74%
51,418 $1.68 Million
Q4 2019

Feb 12, 2020
BUY
$32.92 - $37.36 $74,333 - $84,358
2,258 Added 5.16%
46,017 $1.8 Million
Q3 2019

Nov 12, 2019
BUY
$32.49 - $42.13 $39,962 - $51,819
1,230 Added 2.89%
43,759 $1.57 Million
Q2 2019

Aug 13, 2019
SELL
$36.98 - $41.52 $17,084 - $19,182
-462 Reduced 1.07%
42,529 $1.84 Million
Q1 2019

May 13, 2019
BUY
$37.5 - $41.2 $174,600 - $191,827
4,656 Added 12.15%
42,991 $1.83 Million
Q4 2018

Feb 13, 2019
BUY
$38.47 - $43.86 $28,236 - $32,193
734 Added 1.95%
38,335 $1.67 Million
Q3 2018

Nov 07, 2018
BUY
$34.47 - $41.81 $14,925 - $18,103
433 Added 1.16%
37,601 $0
Q2 2018

Aug 03, 2018
BUY
$32.98 - $35.16 $71,830 - $76,578
2,178 Added 6.22%
37,168 $0
Q1 2018

May 14, 2018
BUY
$31.91 - $37.02 $15,252 - $17,695
478 Added 1.39%
34,990 $1.24 Million
Q4 2017

Feb 14, 2018
BUY
$33.26 - $35.29 $1.15 Million - $1.22 Million
34,507 Added 690140.0%
34,512 $1.25 Million
Q4 2017

Feb 12, 2018
SELL
$33.26 - $35.29 $1.2 Million - $1.27 Million
-36,079 Reduced 99.99%
5 $1,000
Q3 2017

Nov 06, 2017
BUY
$31.0 - $34.15 $1.12 Million - $1.23 Million
36,084
36,084 $1.29 Million

Others Institutions Holding PFE

# of Institutions
3,218
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email